Boston Partners
BEAT

Boston Partners’s BioTelemetry, Inc. BEAT Stock Holding History

Boston Partners’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-79,097
Closed -$467K – 755
2013
Q2 		$467K Buy
+79,097
New +$266K ﹤0.01% 661

Other funds holding BEAT

CPIM
Columbia Partners Investment Management Alexandria, Virginia $257M AUM 8.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SC
Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TI
Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return

Boston Partners's BEAT Position: Q3 2013 in Review

Boston Partners sold out of BioTelemetry, Inc. (BEAT) in Q3 2013, closing a stake of 79,097 shares — an estimated $467K sold.

Boston Partners first reported a position in BEAT in Q2 2013 and held it in 1 quarter. The position peaked at $467K in Q2 2013. 75 funds tracked by Wall St. Rank hold BEAT as of Q3 2013.

  • Boston Partners reported no remaining BioTelemetry, Inc. position as of Q3 2013 after selling out during the quarter.
  • Boston Partners sold 79,097 BioTelemetry, Inc. shares in Q3 2013, an estimated $467K.
  • Boston Partners first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 1 quarter.
  • Boston Partners's BioTelemetry, Inc. position peaked at $467K in Q2 2013.
  • 75 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2013.

Based on Boston Partners's 13F filing for Q3 2013, filed 12 Nov 2013.